On May 21, 2026, India's Central Drugs Standard Control Organisation (CDSCO) issued a clear directive: no injectable product can be classified or sold as a cosmetic. The directive, reported by…
The Central Drugs Standard Control Organisation (CDSCO) has waived the requirement for local Phase 3 clinical trials for generic versions of lenacapavir, a breakthrough HIV prevention drug, moving India significantly…
India's pharmaceutical industry supplies over 20% of the world's generic medicines by volume. For international buyers — hospitals, pharmacies, procurement agencies, and individual patients — the safety and quality of…
India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…